Annual Operating Expenses:
$569.55M+$176.50M(+44.91%)Summary
- As of today, PCVX annual total operating expenses is $569.55 million, with the most recent change of +$176.50 million (+44.91%) on December 31, 2024.
- During the last 3 years, PCVX annual operating expenses has risen by +$467.46 million (+457.91%).
- PCVX annual operating expenses is now at all-time high.
Performance
PCVX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$237.18M+$15.95M(+7.21%)Summary
- As of today, PCVX quarterly total operating expenses is $237.18 million, with the most recent change of +$15.95 million (+7.21%) on September 30, 2025.
- Over the past year, PCVX quarterly operating expenses has increased by +$101.76 million (+75.14%).
- PCVX quarterly operating expenses is now at all-time high.
Performance
PCVX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PCVX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +44.9% | +75.1% |
| 3Y3 Years | +457.9% | +321.9% |
| 5Y5 Years | +956.4% | +1029.0% |
PCVX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +457.9% | at high | +321.9% |
| 5Y | 5-Year | at high | +956.4% | at high | +1140.4% |
| All-Time | All-Time | at high | +1502.9% | at high | +1903.2% |
PCVX Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $237.18M(+7.2%) |
| Jun 2025 | - | $221.23M(+25.8%) |
| Mar 2025 | - | $175.92M(+11.8%) |
| Dec 2024 | $569.55M(+44.9%) | $157.38M(+16.2%) |
| Sep 2024 | - | $135.42M(-9.4%) |
| Jun 2024 | - | $149.50M(+34.2%) |
| Mar 2024 | - | $111.38M(-6.2%) |
| Dec 2023 | $393.04M(+87.8%) | $118.73M(+7.4%) |
| Sep 2023 | - | $110.55M(+30.4%) |
| Jun 2023 | - | $84.75M(+23.1%) |
| Mar 2023 | - | $68.85M(+12.4%) |
| Dec 2022 | $209.26M | $61.28M(+9.0%) |
| Sep 2022 | - | $56.22M(+23.0%) |
| Jun 2022 | - | $45.72M(+24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $36.85M(+28.7%) |
| Dec 2021 | $102.08M(+17.2%) | $28.64M(+9.7%) |
| Sep 2021 | - | $26.11M(+14.2%) |
| Jun 2021 | - | $22.86M(+1.1%) |
| Mar 2021 | - | $22.62M(+18.3%) |
| Dec 2020 | $87.10M(+61.6%) | $19.12M(-9.0%) |
| Sep 2020 | - | $21.01M(+0.9%) |
| Jun 2020 | - | $20.82M(-23.5%) |
| Mar 2020 | - | $27.21M(+75.5%) |
| Dec 2019 | $53.92M(+51.7%) | $15.51M(+31.0%) |
| Sep 2019 | - | $11.84M(-0.8%) |
| Jun 2019 | - | $11.93M(-12.6%) |
| Mar 2019 | - | $13.65M |
| Dec 2018 | $35.53M | - |
FAQ
- What is Vaxcyte, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual operating expenses year-on-year change?
- What is Vaxcyte, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly operating expenses year-on-year change?
What is Vaxcyte, Inc. annual total operating expenses?
The current annual operating expenses of PCVX is $569.55M
What is the all-time high annual operating expenses for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual total operating expenses is $569.55M
What is Vaxcyte, Inc. annual operating expenses year-on-year change?
Over the past year, PCVX annual total operating expenses has changed by +$176.50M (+44.91%)
What is Vaxcyte, Inc. quarterly total operating expenses?
The current quarterly operating expenses of PCVX is $237.18M
What is the all-time high quarterly operating expenses for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly total operating expenses is $237.18M
What is Vaxcyte, Inc. quarterly operating expenses year-on-year change?
Over the past year, PCVX quarterly total operating expenses has changed by +$101.76M (+75.14%)